Archive for May, 2018

$PVOTF Signs Option Agreement to Acquire Licensing Rights to TriVair™

VANCOUVER, May 31, 2018 – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that the Company has signed an Option Agreement with IP Med Inc., based in Oceanside, New York, to acquire an exclusive worldwide license for Trivair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the delivery of Pivot’s Ready-To-Infuse-Cannabis (“RTIC”) cannabinoid products. The Option expires in 6-months during which time Pivot will determine compatibility with Pivot’s RTIC powder formulations. Upon successful completion of the evaluation Pivot will have the Option to enter into a Definitive Licensing Agreement with IP Med for the TriVair™ device.

Winner of the Frost and Sullivan 2009 European Drug Delivery Product Differentiation Innovation of the Year Award, the intuitive and easy-to-use TriVair™ patented devices are discreet and disposable, deliver pre-loaded precise unit doses and eliminate the risk of microbial contamination. Clinical studies using the TriVair™ Delivery System have demonstrated that the powder compound is widely distributed in all areas of the nasal cavity (with no area of powder accumulation), is effective in retaining medication in the nasal cavity without pharyngeal penetration and showed a high degree of patient acceptability.

The TriVair™ Nasal device uses the body’s natural breath to propel a medication deep into the nasal cavity to targeted sites, bypassing the Blood Brain Barrier, providing the potential to better treat central nervous system diseases such as migraines, epilepsy, insomnia, and post-operative pain, the latter of which is often remedied by opioids. The TriVair™ Pulmonary device enables specific dosing to the pulmonary airways, thereby targeting the lungs. Such targeting can be highly relevant in the treatment of respiratory diseases and in the prevention and treatment of respiratory infections.

Pivot will combine its patented RTIC™ cannabis powder technology with the TriVair™ delivery system to provide a rapid onset effect for patients and consumers in markets where regulations permit. Pivot’s Product Formulation Team, led by Dr. Leonid Lurya in Israel, has initiated testing to evaluate, modify and test formulations that achieve the desired particle size for delivery by the TriVair™ device.

IP Med’s Vice-President, Mr. Ben Isaacs, comments that “I am excited to partner with the team at Pivot Pharmaceuticals. With their product development and commercialization experience, and impressive RTIC powdered cannabis technology I am confident that the TriVair™ device will provide a safe and effective way for the delivery of cannabinoids into patients.”

Dr. Joseph Borovsky, Pivot’s Executive Vice President, Product Development, stated “We are very pleased to add the TriVair™ device to Pivot’s product line and expand the range of delivery systems for cannabinoids. This pre-loaded and single-use device, will be a disruptive technology and provide solutions for patients with special medical needs.”

Pivot’s Chief Medical Officer, Dr. Wolfgang Renz commented “Pivot continues to grow its portfolio of patented technologies specifically for the formulation and delivery of cannabinoids. We are very excited about the unique opportunity this differentiated product presents for patients seeking an alternative method to traditional cannabis practices. Upon the completion of our compatibility testing, Pivot will have the world’s first nasal and pulmonary powdered cannabis device for quick onset and use in the medical field. This combination product may be well suited for managing such indications as sleep disorder, migraine, late-stage cancer pain, and address opioid withdrawal.”

About IP Med Inc.

IP Med partners with (physician) inventors, academic institutions and pharmaceutical companies to bring their concepts to market: We create, develop (design and engineer), patent, prototype, build proof of concept, commercialize and/or monetize unique and innovative technologies and compounds in efficient and cost effective ways. IP Med’s founders bring 35 + years of success and experience in strategic planning and marketing for the pharmaceutical and medical product industries; working with top-tier companies including Pfizer, Wyeth, Eli Lilly, Merck, AstraZeneca and GlaxoSmithKline just to name a few. IP Med maintains close relationships with a vast network of executives within major companies in the medical arena; including pharmaceutical, biotech and medical device companies. For more information please visit www.ipmedinc.com

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis oil-to-powder technology, BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. For more information please visit www.PivotPharma.com

Cautionary Statement

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, IP Med Inc., or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot’s products, statements with respect to internal expectations, including with respect to the TriVair device, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot’s expansion efforts, economic conditions in the industry, and the financial strength of Pivot’s customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Thursday, May 31st, 2018 Uncategorized Comments Off on $PVOTF Signs Option Agreement to Acquire Licensing Rights to TriVair™

$DJACF Files 2018 First Quarter Results

TORONTO, May 31, 2018 – Hiku Brands Company Ltd. (CSE: HIKU) (“Hiku” or the “Company”) is pleased to announce the filing of its financial statements and management discussion and analysis for the first quarter ended March 31, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.

“The first quarter of 2018 was one that focused on solidifying our vertically integrated cannabis company and positioning us to win in the legal adult-use market in Canada.” said Alan Gertner, CEO of Hiku. “With our solid foundation of Tokyo Smoke and its existing retail footprint, our artisanal handcrafted cannabis grown at DOJA‘s state of the art facility in British Columbia, and our iconic brands like Van der Pop and Maïtri, we believe that Hiku is very well positioned to usher in the adult-use cannabis sector in Canada”.  Mr. Gertner added, “We are excited about our announced merger with WeedMD, a recognized leader in the medical cannabis sector. WeedMD brings considerable scalable production and seasoned R&D capabilities giving Hiku immediate access to cannabis flower, concentrates and innovative products that we believe will bolster our ability meet customers’ needs in the adult-use market.”

2018 Q1 Highlights

January

  • Launched Hiku – The merger of DOJA Cannabis Company Limited and TS Brandco Holdings Inc. (“Tokyo Smoke”) closed and the combined company was renamed Hiku Brands Company Ltd. – becoming Canada’s first vertically integrated cannabis brand house and uniting the cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

February

  • Awarded Manitoba Retail License – 10006215 Manitoba Ltd. (“Tokyo Smoke Manitoba”), a company of which Hiku owns a 79.9% equity interest, with participation of BOBHQ, was conditionally awarded one of four master retail licenses in Manitoba’s Request for Proposal process for the opportunity to operate retail cannabis stores. The license gives Tokyo Smoke Manitoba the ability to operate legal retail cannabis stores and an online cannabis e-commerce platform in Manitoba.
  • Entered into First International Partnership in Jamaica – Hiku entered into a letter of intent with Kaya Inc., the first licensed medical cannabis producer and dispensary operator in Jamaica, to launch a strategic alliance to pursue medical and adult-use cannabis branding, genetics, and retail opportunities in Jamaica and Canada.

March

  • Announced Cannabis Oil Partnership – Signed a strategic partnership agreement with Vitalis Extraction Technology Inc., a Kelowna-based company at the forefront of CO2 extraction innovation.
  • Bolstered Leadership Team – Made several key additions to the leadership team with significant expertise in retail, branding, government relations and communications.
  • Redefining the Cannabis Retail Experience – Entered into an exclusive collaboration agreement with Jackman Reinvention Inc. (a strategic and creative brand consultancy with deep experience in retail execution) to create a blueprint for Hiku’s dispensary build-outs in select provinces.
  • Bringing Exceptional Products to MarketEntered into a letter of intent to establish a co-marketing, retail and select distribution relationship with GSW Creative Corporation Inc., d/b/a dosist (“dosist”) (previously known as hmbldt), a leading wellness brand providing consistent, controlled and effective cannabis-based solutions.

Q2 2018 Highlights to Date

April

  • Received Sales License – DOJA Cannabis Ltd. (“DOJA”), a wholly-owned subsidiary of Hiku, received an amendment to its sales license from Health Canada to include the sales of dried cannabis, cannabis plants and seeds.
  • Hiku & WeedMD Merger – Hiku entered into a definitive agreement to merge with WeedMD Inc. (“WeedMD”), which would combine a premium cannabis brand house and retail focused operator in Hiku, with the significant production capabilities and differentiated medical brand in WeedMD (the “WeedMD Merger”). If the WeedMD Merger is completed, the combined company would have a diversified cannabis cultivation platform with four facilities from coast-to-coast with planned expansion capacity to potentially have the ability to produce over 56,000 kg by mid-2019.

May

  • Acquired Quebec-Based Cannabis Brand Maïtri – The Company acquired 100% of the issued and outstanding shares of Maïtri Group Inc. (“Maïtri”), a Quebec-based cannabis accessory and design brand.
  • De-levered the Company’s Balance Sheet – The Company offered the opportunity for eligible holders of 8% unsecured convertible debentures of Hiku due December 28, 2020 (the “Debentures”), whom in aggregate held $16,693,000 in principal, to elect to convert their Debentures during the period between May 17, 2018 and June 7, 2018 at the conversion price and in return receive an additional 250 common share purchase warrants (“Early Conversion Warrants”) of Hiku per $1,000 of principal amount of Debentures converted, in addition to the common shares of Hiku to be received in connection with such conversion. As at May 30, 2018, debentureholders owning $12,500,000 of outstanding Debentures elected to convert early and the Company now only has $4,193,000 in principal amount of Debentures outstanding.
  • Newfoundland & Labrador Investment – The Company entered into a binding letter of intent (the “Oceanic LOI”) with Oceanic Releaf Inc. (“Oceanic”) and the sole shareholder of Oceanic. Oceanic is a Newfoundland & Labrador-based late-stage applicant under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Under the terms of the Oceanic LOI, Hiku will invest up to $1,000,000 in cash and up to $2,000,000 worth of common shares of Hiku in exchange for 25% of the post-closing aggregate issued and outstanding shares of Oceanic on a fully-diluted basis (the “Oceanic Strategic Investment”). In connection with the Oceanic Strategic Investment and pursuant to the Oceanic LOI, Hiku and Oceanic intend to become licensed for cannabis retail locations within the province, and will enter into a retail agreement governing the operation of these stores. The Oceanic Strategic Investment is contingent upon securing retail licenses from the Government of Newfoundland & Labrador allowing Hiku to operate stores within the province.

About Hiku Brands

Hiku is focused on building a portfolio of engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA’s ACMPR licensed grow, and Van der Pop’s female-focused educational platforms, Hiku houses a portfolio that aims to set the bar for cannabis brands in Canada.

Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed to cultivate and sell cannabis pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. Tokyo Smoke Manitoba, a company of which Hiku owns a 79.9% equity interest, has been conditionally awarded one of four master retail licenses in Manitoba. Hiku also operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Forward-looking statements

This news release contains statements that constitute “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Hiku’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements in this document include, among others, the Company’s expectations concerning the completion of the WeedMD Merger, the planned production capacity of the combined company, the arrival of the adult-use cannabis market, the Company’s planned operations in Manitoba, the Company’s strategic alliance with Kaya Inc. and any future operations in Jamaica, the build-outs of the Company’s facilities and future dispensaries (if any) and the completion of the Oceanic Strategic Investment (if at all) and the terms thereof. By their nature, forward-looking statements are based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Hiku is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not approved nor disapproved the contents of this news release.

SOURCE Hiku Brands Company Ltd.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/31/c4435.html

Will Stewart, Vice President, Corporate Communications & Public Affairs, WStewart@Hiku.com, 416-899-9422Copyright CNW Group 2018

Thursday, May 31st, 2018 Uncategorized Comments Off on $DJACF Files 2018 First Quarter Results

$ETST Eyes Future Uplisting to OTCQB Venture Market

  • ETST issues new audio press release regarding its audits, Form 10, financing plans and fully reporting status
  • ETST has started 2017 fiscal year audit, which is required, along with the approved Form 10, to uplist to the OTCQB Venture Market
  • Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol (CBD)

Earth Science Tech, Inc. (OTC: ETST) recently released an audio press release discussing its future financial plans and its previously announced completion of audits and Form 10 submission, which could lead to an uplisting to the OTCQB Venture Market (http://cnw.fm/Fvs2f).

ETST has completed its audit for FY2015 and FY2016 and submitted its Form 10 to be fully reporting (http://cnw.fm/3kYLe), and it is currently conducting its audit for FY2017. That audit and the approved Form 10 submission, together, are needed for an uplisting to the OTCQB Venture Market.

ETST, a biotech company based in Doral, Florida, has repositioned its line of full-spectrum cannabidiol products. It also conducts R&D for low cost, non-invasive medical devices, as it concentrates on manufacturing, marketing and distributing its cannabinoid products to the nutraceutical and pharmaceutical markets.

Dr. Michel Aube, CEO and chief science officer of ETST, said that transparency is a key tool in the expansion of the company’s business and maintaining the confidence of investors. In a news release, he added, “Since all of our amazing projects are ongoing with our partners, investor confidence will grow, and we will be able to complete our first big round of financing.”

Nickolas Tabraue, director and president of ETST, said, “Thanks to our passionate, likeminded team, the transition should be smooth as we continue growing. I look forward to sharing updates on the full reporting process as it progresses.”

ETST holds four wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit to accept grants and donations for conducting additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Thursday, May 31st, 2018 Uncategorized Comments Off on $ETST Eyes Future Uplisting to OTCQB Venture Market

$SNNVF SeriousTraders Puts Spotlight on Sunniva

Every month, SeriousTraders issues a newsletter to its subscribers jam packed with specialized articles; you won’t miss an opportunity to hone your trading edge.

Here are the 14 companies featured this month:

Aftermaster, Inc. (OTCQB: AFTM), with offices in Scottsdale, Arizona, and Hollywood California, is an award-winning, leading-edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. The company also operates world-class mastering and recording studios located in the heart of Hollywood, California, in the famous Crossroads of the World complex along Sunset Boulevard. Click here to read the full profile.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government. Click here to read the full profile.

BLOCKStrain Technology Corp. (TSX.V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership. Click here to read the full profile.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada. Click here to read the full profile.

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida. Click here to read the full profile.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric “argument engine” measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards. Click here to read the full profile.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades. Click here to read the full profile.

Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology. Click here to read the full profile.

Net Element, Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies. Click here to read the full profile.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism. Click here to read the full profile.

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide. Click here to read the full profile.

Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation. Click here to read the full profile.

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices. Click here to read the full profile.

The Green Organic Dutchman (TSX: TGOD), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada). Click here to read the full profile.

Newsletter Sign-Up

To receive our monthly newsletter, please sign up at the following link: http://SignUp.SeriousTraders.com

About SeriousTraders

SeriousTraders is designed for serious traders who want to know about the hottest, most undervalued stocks before the rest of the investment community. We know these traders believe that it is imperative to stay on top of the market at all times, and we stand behind them by continually searching for incredible trading opportunities. For more information, visit www.SeriousTraders.com

Please see full disclaimers on the SeriousTraders website: http://www.serioustraders.com/disclaimer.php

Thursday, May 31st, 2018 Uncategorized Comments Off on $SNNVF SeriousTraders Puts Spotlight on Sunniva

$CIIX Subsidiary Expands Sales Force to Grow Division’s Domestic Revenues

  • ChineseInvestors.com is the foremost financial information website for Chinese-speaking investors
  • The company provides premier, real-time market commentary, analysis and educational services in the Chinese language
  • ChineseInvestors.com’s wholly owned subsidiary is ChineseHempOil.com, Inc.

California-based ChineseInvestors.com, Inc. (OTCQB: CIIX) operates the foremost financial information website for Chinese-speaking investors. A fintech company, ChineseInvestors.com provides online financial information in Chinese language character sets. This includes traditional and simplified character sets. This financial information is for the Chinese population in the United States and around the world. The company’s subscriber base includes free as well as paying members, mainly located in the United States and Canada.

The emphasis today is on companies that can provide first-rate information that brings greater transparency to investors. The CFA Institute (http://cnw.fm/MAR5q) states that “the use of data and technology can result in a more effective and efficient overall financial reporting process in which investors… receive more transparent, better-quality information on a timely basis.”

ChineseInvestors.com works to provide better-quality information by focusing on making available premier, real-time market commentary, analysis and educational services in the Chinese language. A premier financial information company, its services are primarily delivered to U.S. public and private companies and U.S. residents and citizens. In addition, the company’s focus is on providing advertising and public relations-related support services, helping companies to better link to the large and growing Chinese community.

ChineseInvestors.com’s wholly owned subsidiary is ChineseHempOil.com, Inc., which offers CBD (cannabidiol) oil and hemp oil products. This subsidiary has expanded its domestic sales force and has appointed Nina Wang as its vice president of sales for its United States Consumer Retail/E-Commerce Division. This furthers the process to complete the spinoff of all of ChineseInvestors.com’s hemp-related assets. Wang joined ChineseHempOil.com in March of this year. Since then, she has hired a team of sales representatives centered on wholesale and consignment sales in the Los Angeles area.

In a news release, Warren Wang, ChineseInvestors.com’s chief executive officer, said, “With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang’s leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company’s hemp related assets.”

Wang has more than 15 years’ sales experience in the financial services industry. She has over 10 years of experience as a merchant services sales manager at USA First Credit Card, Inc. Before that, she worked as a sales manager for Alliance Bank Card Services.

The spin-off of all of ChineseInvestors.com’s hemp-related assets was originally scheduled for May 31, 2018. The spin-off has been temporarily postponed as the company continues to develop its domestic sales channels.

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Thursday, May 31st, 2018 Uncategorized Comments Off on $CIIX Subsidiary Expands Sales Force to Grow Division’s Domestic Revenues

$FRSX TinyGems Newsletter Feature

Every month, TinyGems features undiscovered, undervalued companies generating heaps of free cash flow, or have the potential to do so in the future. These gems are ripe for the mining, if you’re willing to take a look.

Here are the seven companies featured this month:

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils. Click here to read the full profile.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades. Click here to read the full profile.

Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology. Click here to read the full profile.

Net Element, Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies. Click here to read the full profile.

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices. Click here to read the full profile.

The Green Organic Dutchman (TSX: TGOD), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada). Click here to read the full profile.

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally. Click here to read the full profile.

Newsletter Sign-Up

To receive our monthly newsletter, please sign up at the following link: http://SignUp.TinyGems.net

About TinyGems

TinyGems features companies that often fly under the radar of Wall Street and could become diamonds in your portfolio. Small-cap stocks have largely earned a bad rap among the investment community. While the small-cap space is unarguably littered with “foul” play, there is a growing number of legitimate, innovative and high-potential companies waiting to be discovered. For more information, visit www.TinyGems.net

Please see full disclaimers on the TinyGems website: http://disclaimer.tinygems.net/disclaimer.html

Thursday, May 31st, 2018 Uncategorized Comments Off on $FRSX TinyGems Newsletter Feature

$VSQTF Portfolio Company FansUnite Closes Oversubscribed Private Placement

VANCOUVER, British Columbia, May 31, 2018 — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce portfolio company, FansUnite Entertainment Inc. (“FansUnite”), has raised $4,457,750 CAD in a private placement financing (the “Private Placement”) valuing FansUnite at over $17,000,000 CAD.

Victory Square incorporated FansUnite earlier this year in order to prepare for an arrangement to spin out the assets of its FansUnite division, which includes an operating subsidiary, FansUnite Media Inc. (acquired 2016). As a result of share issuances from the treasury of FansUnite for nominal consideration to management and market partners and to subscribers pursuant to the Private Placement, the Company’s interest in FansUnite has decreased from 100% to 48.55%. The Private Placement was undertaken as part of FansUnite’s strategy to maximize shareholder value, which includes going public in the fourth quarter of 2018.

FansUnite is focused on utilizing the benefits of blockchain technology to disrupt the sports, gaming, and entertainment industries. FansUnite’s current key offerings are:  the FansUnite Protocol – a protocol level standard for sports betting and sports data applications, built on the Ethereum blockchain;  the FansUnite Sportsbook – the first decentralized application leveraging the FansUnite Protocol, offering an industry low margin and social elements designed to encourage user collaboration; and subsidiary company FansUnite Media Inc. – a free to play social sports betting community designed to track and analyze results, collaborate with fellow members, and to place fantasy wagers with no monetary risk.

FansUnite is continuing to develop the FansUnite Protocol, Sportsbook, and other applications, and pursuing M&A activity in the sports, gaming and entertainment industries.

The United States Supreme Court ruling on May 14, 2018, allowing the legalization of sports betting on a state-by-state basis has created a significant new regulated sports betting market.  FansUnite’s welcoming of regulatory overview, the transparency inherent in blockchain technology, and the industry low margins that FansUnite has created will be a massive win for bettors and fantasy players alike.

“We’re extremely pleased with the impressive oversubscription of the FansUnite private placement,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “FansUnite is utilizing blockchain technology in an industry ripe for growth and have the opportunity to build a protocol that can significantly change the landscape of the sports betting and sports data industries,” said Diamond.

“This is a great milestone for our FansUnite Team,” said Darius Eghdami, Chief Executive Officer of FansUnite. “We’ve assembled a strong team with decades of experience in the sports betting industry and are excited to build a more efficient, transparent and regulated platform.”

Rounding out FansUnite’s executive team of Darius Eghdami, and Duncan McIntyre, Chief Operating Officer, FansUnite has engaged Graeme Moore as Chief Financial Officer. Graeme, a Chartered Professional Accountant, was previously the Controller at Traction on Demand, and lead the finance department of one of Canada’s Best Managed Companies.
http://www.canadianbusiness.com/lists-and-rankings/best-managed-companies/traction-on-demand/

For further information about the Company, please contact:

Investor Relations Contact – Prit Singh
Email: prit@victorysquare.com
Telephone: 905-510-7636

Media Contact – Howard Blank, Director
Email: howard@victorysquare.com
Telephone: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance by any portfolio company of the Company, the impact of any portfolio company’s performance on the Company, the strategic direction of the Company, and the potential spin out of its FansUnite division and strategy thereof for going public. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical fact contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Thursday, May 31st, 2018 Uncategorized Comments Off on $VSQTF Portfolio Company FansUnite Closes Oversubscribed Private Placement

$PBIO PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs

  • Biologics offer novel ways of treating degenerative diseases like Alzheimer’s
  • Biologics are one of the fastest-growing drug categories
  • PreEMT™ technology improves quality, reduces cost of biologic manufacture

When we think of drugs, an image of potions in round-bottom flasks conjured up in labs comes to mind, or perhaps pills of one sort or another ingested with a sip of water, for about 90 percent of drugs currently in use have that profile. However, discovering that the human body will act as its own physician by dispensing protective proteins called antibodies to fight the toxins that bring on diseases has spurred efforts, naturally enough, to develop those proteins synthetically. This new class of biotherapeutic protein drugs, or biologics, tends to be more effective at combating pathological conditions with less side effects, since they mimic endogenously produced proteins, which target highly specific parts of the invader (antigens). Unfortunately, the production of biologics is easier said than done; it typically requires hundreds of process steps to assemble one of these complex biotherapeutic proteins. Therefore, it should come as no surprise that the PreEMT™ platform recently acquired by Pressure BioSciences Inc. (OTCQB: PBIO) is a welcome addition to biologic development.

The company recently announced the signing of an agreement with an international biopharmaceutical company to assess the potential of the PreEMT™ technology as the basis for a unique manufacturing process and as an enhancement to the quality of a key protein-based drug currently under development (http://nnw.fm/Yr5lG).

Many currently available drugs are synthesized chemically, with molecular structures that are “well defined and relatively simple” (http://nnw.fm/abUv6). Their simplicity makes them easy to produce and easy for the human body to assimilate. A good example is acetylsalicylic acid (ASA), the active ingredient in aspirin, which has a molecular weight of about 180 grams per mole. Generally, such drugs are swallowed in pill or liquid form before entering the gastrointestinal system and blood stream by diffusion through the intestinal wall. Once in the blood, they have access to the entire body, their tiny size allowing them to penetrate cell membranes easily.

Biologics, by contrast, are much larger compounds that mimic the complex endogenous proteins produced by the immune system. They are generally composed of hundreds of amino acids and may carry a weight as high as 150,000 grams per mole. Biologics will bind to the specific cell receptors associated with a particular disease. For example, monoclonal antibodies are adept at recognizing very specific structures on the surface of cells. This specificity means that healthy cells are not adversely affected, resulting in less side effects. This is one reason that treatment by biologics can be superior to regimens developed with traditional combinatorial chemistries.

Because of their complexity, the manufacture of biotherapeutic proteins is prone to errors, very often falling prey to aggregation and misfolding. Misfolding occurs when the normal, three-dimensional structure of a protein becomes distorted, which may lead the protein to aggregate, a result that is quite the opposite of the benign outcomes intended in the manufacture of biologics. Many pathological conditions occur naturally by misfolded proteins. The list includes Alzheimer’s disease, which affects about 10 percent of the adult population over 65 years old in North America, as well as Parkinson’s disease and Huntington’s disease. However, PBIO’s PreEMT patented technology could reduce the incidence of misfolding in manufacture.

“PreEMT results in the dissolution of protein aggregates, which may have a significant impact on the quality of protein drugs by improving protein activity, homogeneity, and stability, as well as by reducing undesirable immunogenic properties”, Dr. Alexander Lazarev, PBIO’s vice president of R&D, stated in a news release.

Richard T. Schumacher, president and CEO of PBIO, added “Importantly, should the PreEMT technology result in more efficient production of high quality protein-based therapeutics for any biopharmaceutical company developing new protein-based therapeutics, manufacturing-scale licenses have the potential to generate millions of dollars in annual royalty revenue for PBIO.”

The technology is likely to find application across a wide range of proteins in reducing aggregation levels in bulk or final formulations, thereby improving product safety. PreEMT is scalable, and it is expected to significantly reduce manufacturing costs.

The acquisition of the PreEMT technology gives PBIO a footprint in the very large and growing biologics contract research services sector. The company is also busily developing its recently patented Ultra Shear Technology (UST) platform. The scalable, pressure-based UST technology creates stable nanoemulsions of otherwise immiscible fluids. It can be used to extend the shelf life of homogenized dairy products without refrigeration, for example. All the while, PBIO continues its focus on its core product line that generated $2.2 million in 2017 revenue: the development of pressure cycling technology (PCT)-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications.

For more information, visit the company’s website at www.PressureBioSciences.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, May 30th, 2018 Uncategorized Comments Off on $PBIO PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs

$NETE Integrated Payment Solution Targets Multibillion-Dollar Events Industry

  • U.S. meetings and events industry generates more than $330 billion annually in direct spending and more than $845 billion in business sales
  • Unified Payments’ solution significantly streamlines and simplifies event processing
  • Solution enhances existing acceptance services with intelligent integration for point-of-sale systems, self-order kiosks, chargeback protection and multi-channel payment acceptance

In the United States, the meetings and events industry is continually expanding across all segments and is a driving force that supports almost six million jobs and pumps hundreds of billions of dollars into the nation’s economy. Recent data from the Events Industry Council indicates that this industry currently generates more than $330 billion in direct spending and over $845 billion in business sales annually.

Leading global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) is establishing a foothold in this robust market with the launch of a brand new intelligent payment solution created specifically for the events industry.

Unified Payments, a subsidiary of Net Element, now offers a complete solution for event processing that enables merchants to maximize their sales, shorten their ticket lines and enhance the overall customer experience. The company’s unique solutions go into action the instant that ticket sales commence for an event, and the robust package offered by Unified Payments transforms event processing and makes it significantly simpler overall.

Unified Payments’ solution boosts existing acceptance services with intelligent integration for point-of-sale systems, self-order kiosks, chargeback protection and multi-channel payment acceptance. Program options like Fast Pass Funding, same-day funding, Zero Pay and the Complimentary Equipment Placement Program are offered to all events industry merchants throughout North America.

The Zero Pay program enables merchants to collect 100 percent of the sales revenue for their event through a cash payment discount for customers who pay by check, credit or debit card. This program includes free equipment rental, mobile point-of-sale, an optional e-commerce platform, same-day funding, an onsite technician and an analytics platform.

The Standard Plan offered to event merchants allows them to accept payments regardless of where a customer is located or how they are paying. With this plan, merchants can unify all payments and optimize the payment acceptance process. The Standard Plan includes free equipment rental, mobile point-of-sale, self-order kiosks, an optional e-commerce platform, an onsite technician, same-day funding and an analytics platform.

The feature-rich payment acceptance solutions now made available for event managers and merchants through Net Element and Unified Payments have the potential to revolutionize the way event transactions are processed. Additional information can be found at http://nnw.fm/LhTv9.

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, May 30th, 2018 Uncategorized Comments Off on $NETE Integrated Payment Solution Targets Multibillion-Dollar Events Industry

$FRSX JGR Capital Initiates Coverage

NEW YORK, May 30, 2018 — via NetworkWire — JGR Capital, an independent equity research firm, announces it has initiated coverage on Foresight Autonomous (NASDAQ:FRSX), a development-stage technology company that develops powerful and mature proprietary stereoscopic technology used in the automotive industry.

The full report can be found here: https://www.jgrcap.com/foresight-autonomous/

Foresight Autonomous (“Foresight,” “FRSX” or the “Company”) is a development-stage technology company that develops stereoscopic technology derived from the field-proven security technology of its major shareholder, Magna BSP. The stereoscopic technology is an image processing concept that uses synchronized cameras to mimic human depth perception and deliver a 3D view. FRSX’s systems create and analyze 3D images in order to foresee possible collisions in roadway environments while also providing highly accurate real-time alerts with near-zero false alerts. ​The Company’s proprietary stereoscopic and quad-camera technology is based, in part, on intellectual property that it has transferred from Magna BSP. Magna’s field-proven security technology has been deployed for almost two decades in critical facilities worldwide, including borders, nuclear plants and airports. FRSX’s main products are:

  • QuadSight System, a four-camera multi-spectral vision system featuring near-100% obstacle detection under all weather and lighting conditions and targeting the semi-autonomous and autonomous vehicle market.
  • Eyes-On ADAS System, a stereo vision Advanced Driver Assistance System (ADAS) backed by advanced algorithms.
  • Eye-Net V2X System, a cellular-based accident prevention system.

Foresight Autonomous is operating in a lucrative market, as the demand for ADAS is expected to increase over the next decade. Additionally, the company is diversifying by seeking international opportunities as well as leveraging its opportunities within the rail industry.

Key Report Highlights

  • Top-down worldwide vehicle market is growing steadily with tremendous potential and demand in ADAS and autonomous driving technologies.
  • FRSX rapidly develops automotive vision solutions for ADAS and semi/fully autonomous vehicles.
  • Foresight emphasizes its IP patents and trademarks as well as core R&D, with over 450% YoY growth in the expenditures.

Disclosures pertaining to this Foresight Autonomous report can be found at www.jgrcap.com.

About Foresight Autonomous

Foresight Autonomous is an Israel-based automotive technology company engaged in the design, development, and commercialization of stereo/quad-camera vision systems based on three-dimensional (3D) video analysis, advanced algorithms and artificial intelligence for image processing and sensor fusion. FRSX develops systems for accident prevention, which are designed to provide real-time information about a vehicle’s surroundings while in motion. The Company targets two vertical markets, advanced driver assistance systems (ADAS) and autonomous/semi-autonomous vehicles, with its two key products of Eyes-On and QuadSight respectively. FRSX also develops and owns a cellular-based accident prevention system named Eye-Net. The Company is headquartered in Ness Ziona, Israel.

About JGR Capital

JGR Capital is an independent equity research firm with a focus on small-cap and pre-IPO companies under $2 billion in market cap. JGR Capital leverages a tech-forward approach to help these companies navigate the market by increasing visibility through equity research. With three locations worldwide, JGR Capital offers analyst coverage via a tech-forward, data-driven approach. Because our reports are based on facts, not recommendations, we are a reputable, trusted resource for investors. For more information, visit www.jgrcap.com

Disclosure

This press release may contain forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the “Risk Factors” section in the SEC filings available in electronic format through SEC Edgar filings at www.SEC.gov.

The research analysts principally responsible for this press release do not receive compensation that is based upon any specific investment banking services or recommendations and can be compensated based on factors relating to the overall profitability of the JGR Capital (“firm”). As of the date of research distribution, neither the firm nor the principal research analysts beneficially own 1% or more of any class of common equity securities for this issuer (including, without limitation, any option, right, warrant, future, long or short position).

The securities of the issuer(s) discussed in this press release may be unsuitable for investors depending on their specific investment objectives and financial position. Past performance is no guarantee of future results. This research does not constitute a personal trading recommendation or take into account the particular investment objectives, financial situation or needs of an individual reader of this report, and does not provide all of the pertinent information to make an investment decision.

Investor Contact

JGR Capital
www.jgrcap.com
Email: research@jgrcap.com
Phone: 646-688-3143

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, May 30th, 2018 Uncategorized Comments Off on $FRSX JGR Capital Initiates Coverage

$SNNVF Grand Opening of Medical Cannabis Clinic in Windsor, Ontario

Vancouver, British Columbia–(May 30, 2018) – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) wholly-owned subsidiary, Natural Health Services Ltd. (“NHS“), Canada’s largest referral network of medical cannabis patients to Licensed Producers (“LPs“) in Canada, is holding an open house for media and the public, today, Wednesday, May 30 at the grand opening of its clinic located at 7900 Anchor Drive in Windsor, Ontario. The facility is one of seven owned and operated patient-centric clinics operating in Alberta, Saskatchewan, Manitoba and Ontario.

NHS Logo

NHS clinics use a unique triage system that provides an uncompromising standard of care from full-time medical professionals across its clinics. NHS provides consultation, medical cannabis education and an introduction to the products and strains available through LPs across Canada. NHS clinics are staffed by physicians, nurses, educators and patient care representatives on-site.

“Consumers are increasingly turning to cannabis for relief from a broad range of medical conditions,” said Dan Vass, President, NHS. “Our clinics allow patients to come in and talk freely and openly with knowledgeable medical professionals who are equipped to recommend the appropriate strain and dose to ensure positive outcomes.”

Medicinal cannabis is increasingly recognized and used to safely treat symptoms related to a wide range of ailments.

The NHS Windsor clinic is accepting new patients. Booking is available at www.naturalhealthservices.ca.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets — Canada and California — where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Sunniva operates through its wholly owned subsidiaries:

Natural Health Services Ltd. (“NHS“) — NHS owns and operates a network of 7 clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through LPs. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. NHS has more than 150,000 active medical documents outstanding and 95,000 active patients.

Sunniva Medical Inc. (“SMI”) — SMI is building the Sunniva Canada Campus, 740,000 square feet of purpose-built cGMP designed greenhouse facilities in British Columbia. The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

CP Logistics, LLC (“CPL“) — Through CPL, Sunniva has commenced construction of the Sunniva California Campus, state-of-the-art, purpose-built greenhouse facilities in Cathedral City, California. The Sunniva California Campus is planned in two phases and has been cGMP designed. Phase 1 is designed to be 325,000-square feet and Phase 2 will be 164,000 square feet. At this facility, it is estimated 30% of all product will be used for higher margin extracted products and all products will be produced free from the pesticides commonly used within today’s industry. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

Full-Scale Distributors, LLC (“FSD“) — FSD, through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers and accessories. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability and FSD will continue to provide these services in coordination with the large supply from both Sunniva Campuses.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, May 30th, 2018 Uncategorized Comments Off on $SNNVF Grand Opening of Medical Cannabis Clinic in Windsor, Ontario

$PVOTF Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

VANCOUVER, May 30, 2018 – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that it has signed an exclusive Contract Manufacturing Agreement (the “Agreement”) with Bio V Pharma Inc. (“BioV”) to manufacture, label, package and supply Pivot’s bio-cannabis product pipeline. BioV is a Quebec-based full-service manufacturer of pharmaceutical and nutraceutical products including vitamins, botanical products, food and veterinary supplements and specializes in capsules, tablets, liquids and semi-solids delivered in a variety of packaging formats.

The BioV management team has over 40 years of experience in product development and manufacturing and will produce Pivot’s entire bio-cannabis suite of products including BiPhasix™ topical creams and lotions, Thrudermic™ transdermal gels and lotions, Solmic™ 1% CBD oral solution, and “RTIC™” Ready-to-Infuse-Cannabis Powder presented in capsules, single-use sachets and bulk packages.

Pivot has engaged Cannabis Compliance Inc. (“CCI”) to apply to Health Canada for a Dealer’s License (“Dealer’s License”) under the Controlled Drugs and Substances Act (“CDSA”) and the Narcotic Control Regulations.  Pivot’s Dealer’s License will be attached to the BioV facility in Dollard-des-Ormeaux, Quebec, enabling the Company to perform research and development, process natural health products, store cannabis derivatives, as well as import and export cannabis oils, concentrates and approved derivatives. In addition, a DL will also allow the Company to formulate cannabis products in various dosage forms, strengths or package sizes to support future market research and product innovation opportunities.

Dr. Patrick Frankham, Pivot’s CEO, stated “We are excited to have chosen Bio V Pharma as our Canadian manufacturing partner at this important time in Pivot’s history. Consumers and regulators will demand high-quality products that are manufactured in cGMP facilities by a knowledgeable and experienced team. BioV has a track record of supplying retail pharmacy chains, including Shoppers Drug Mart and London Drugs, with products meeting the highest quality standards. We continue to execute on our business plan to monetize our platform technologies by commercializing our suite of premium, science-based cannabis products in key markets.”

Pivot is currently in discussions with several Canadian Licensed Producers to secure supply of pharmaceutical-grade cannabis oils and isolates and expects to finalize a Supply Agreement shortly. Upon receipt of a Dealer’s License from Health Canada, Pivot will be ready to market its differentiated portfolio of products to consumers in Canada and the EU.  The Company remains on target to generate revenue in Q4 2018 from its operations in California, Canada and select EU countries.

About Bio V Pharma Inc.

Bio V Pharma is a Canadian based full-service manufacturer of pharmaceuticals and nutraceutical products including vitamins, botanical products, and food supplements. With over 40 years of experience in product development and manufacturing, Bio V currently services North America, Europe & the Middle East and is internationally recognized for quality & service, meeting the most stringent compliance and documentation requirements. For more information please visit www.biov.ca

About Cannabis Compliance Inc.

Cannabis Compliance Inc. offers risk mitigation, due diligence and regulatory compliance for commercial cannabis producers and resellers around the world. We focus in the global market, and provide our clients with trusted and comprehensive solutions. CCI has extensive expertise in regulatory compliance, cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, import & export, staff recruitment and financial planning. CCI exists to empower the future leaders in the global cannabis industry. For more information please visit www.cannabiscomplianceinc.com

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis oil-to-powder technology, BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. For more information please visit www.PivotPharma.com

Cautionary Statement

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, Bio V Pharma Inc., or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot’s products, statements with respect to internal expectations, including with respect to the Dealer’s License, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot’s expansion efforts, economic conditions in the industry, and the financial strength of Pivot’s customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Wednesday, May 30th, 2018 Uncategorized Comments Off on $PVOTF Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

$SNNVF Receives Confirmation of Readiness From Health Canada

VANCOUVER, British Columbia, May 29, 2018  — via NetworkWire – Sunniva Inc. (“Sunniva” or the “Company”) (CSE:SNN)(OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce a major milestone with the receipt from Health Canada of the Confirmation of Readiness (“COR”) for a License under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Sunniva Medical Inc. (“SMI”). This represents acceptance of our detailed application with the next step being an inspection upon site readiness in order to commence cultivation.

The license and the expected completion of the Sunniva Canada Campus will position the Company as a significant supplier to the rapidly growing Canadian cannabis market.  Sunniva previously announced a take or pay supply agreement with Canopy Growth Corporation (“Canopy”). Under the terms of the initial two-year agreement, which includes the distribution of Sunniva branded products, Canopy will purchase approximately 45% of Sunniva’s annual production capacity; representing 45,000 kgs of dried cannabis annually, commencing Q1 2019 or shortly thereafter. The agreement is subject to SMI receiving its license from Health Canada and completing the Sunniva Canada Campus.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/012f0adb-01e8-462a-a0d2-d930ef675403

The Company is also pleased to announce that SMI has received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus, which commenced at the beginning of May, on its previously announced purchased 126-acre site in Okanagan Falls, British Columbia.  Sunniva is currently finalizing the financing via bank and subordinate debt for the planned state-of-the-art 740,000 sq. ft. facility, designed to meet current Good Manufacturing Practice (“cGMP”) standards.

The Company is now focused on building the facility according to the design submitted.  Sunniva is leveraging its experience from their flagship greenhouse facility in California, which is already 5 months into the construction cycle.  In order to confirm readiness, SMI will be required to submit information including documentation, photos, and videos of the Sunniva Canada Campus presenting evidence of all physical security measures in order to receive a cultivation license from Health Canada.

Sunniva has chosen the following vendors in respect to the Sunniva Canada Campus project:

  • Certhon Projects B.V. – supplier of the greenhouse superstructure, electrical, irrigation systems, lighting system and heating, cooling and CO2 systems.
  • EllisDon Corporation – engineering, construction manager and general contractor.
  • MQN Architects – architect consultant.
  • Urban Systems Ltd. – civil and landscape engineers.

“We are pleased to deliver on another key corporate milestone for the Company as we have made an excellent start to 2018 with significant progress on multiple fronts, executing on our strategy, and working toward our goal of creating one of the most efficient, low-cost growing operations to serve the Canadian and California cannabis market,” said Dr. Anthony Holler, CEO, Sunniva. “It is our intention to forward sell an additional 30% of our production capacity in Canada”.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Sunniva operates through its wholly owned subsidiaries:

Sunniva Medical Inc. (“SMI”) – SMI is building the Sunniva Canada Campus, 740,000 square feet of purpose-built cGMP designed greenhouse facilities in British Columbia.  The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

CP Logistics, LLC (“CPL”) – Through CPL, Sunniva has commenced construction of the Sunniva California Campus, state-of-the-art, purpose-built greenhouse facilities in Cathedral City, California. The Sunniva California Campus is planned in two phases and has been cGMP designed. Phase 1 is designed to be 325,000-square feet and Phase 2 will be 164,000 square feet. At this facility, it is estimated 30% of all product will be used for higher margin extracted products and all products will be produced free from the pesticides commonly used within today’s industry. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

Natural Health Services Ltd. (“NHS”) – NHS owns and operates a network of 7 clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through LPs. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. NHS has more than 150,000 active medical documents outstanding and 95,000 active patients.

Full-Scale Distributors, LLC (“FSD”) – FSD, through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers and accessories. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability and FSD will continue to provide these services in coordination with the large supply from both Sunniva Campuses.

For the latest videos and photos of the Sunniva Canada Campus and further information regarding the Company please visit: www.sunniva.com

Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Sunniva’s plan to cultivate, produce and distribute a broad range of solutions focused on patients’ needs and Sunniva’s plans, timing and estimates for its facilities, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, May 29th, 2018 Uncategorized Comments Off on $SNNVF Receives Confirmation of Readiness From Health Canada

$HMMR Plans to Launch IaaS, Cloud Hosting Platform

  • New Jersey-based communications company announces LOI marking “ideal combination of intellectual property”
  • Company’s new IaaS cloud service plans support blockchain and cryptocurrency mining enterprises
  • Hammer aims to position itself as a leader in future 5G technology

An agreement announced on May 8 by Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR) to acquire the stock of 1stPoint Communications, LLC and its subsidiaries represents Hammer’s first acquisition, and furthers Hammer Fiber Optics’ plans to expand its wireless Internet, television, voice and fiber optic carrier services as it considers growing from its New Jersey, New York and Pennsylvania base of operations toward a national network (http://nnw.fm/x3VgV). The acquisition brings important revenue and EBITDA into the model.

Hammer Fiber Optics Holdings’ mission is to spearhead a change in the way television, Internet and phone services are delivered to entertainment-hungry consumers, and the company, doing business as Hammer Communications, is aligning itself with other businesses that embrace the same ideals as their core strengths.

Business models within the wireless, cable TV and media industries are changing as rapid technological advancement drives a convergence of the industries and redefines their parameters, joining their services together in one platform. Wireless networks are a primary catalyst of the overall industry transition (http://nnw.fm/RW6fJ).

The letter of intent for acquisition of 1stPoint Communications, LLC and subsidiaries Open Data Centers, LLC and Endstream Communications, LLC is “an ideal combination of intellectual property,” 1stPoint Communications CEO Erik Levitt stated in a news release. “Hammer will not only have the benefit of the exclusive rights to the patented AIR wireless technology but also to 1stPoint’s switching technology, its underlying CLECs (competitive local exchange carriers) and its Commercial Mobile Radio Services operator.”

In addition, the Open Data Centers facility in New Jersey, which includes its server and switching platforms, is “a significant addition to our core infrastructure to support major growth in the cloud and hosting markets,” Hammer’s founder, Mark Stogdill, stated in the news release.

The company recently revealed plans to launch a cloud hosting and infrastructure-as-a-service platform (IaaS) that offers hosting, cloud and colocation services for blockchain-interested enterprises. Data centers and the energy necessary to use them for cryptocurrency mining can require enormous overhead expenses of businesses, but Hammer’s best-in-class computer servers are prepared to deliver a cloud-based system to those small crypto businesses and free them from the constraints of building and maintaining their own corporate data centers.

Hammer currently serves residential and small businesses in its core market region by supplying high-capacity broadband, voice and video through cabled fiber as well as through its wireless fiber platform. As Hammer adds wholesale services such as backhaul support for cellular network operators, the company expects to position itself as a leader in future 5G technology.

Hammer is leveraging its systems to deliver high-capacity broadband to markets across the country at much lower cost than traditional methods. Live field testing of the new system begins this year with commercial service to follow in the coming months.

In January, the company also announced the launch of a virtual private network service (VPN) to accommodate clients’ concerns about privacy in their Internet usage, one of several ways Hammer is building its infrastructure and carrier grade services.

“We wanted to make sure that our customers had a way to connect and surf the internet away from the scrutiny of internet service providers, even ourselves,” Daniel Corbe, the director of Network Operations, stated in a news release. “Recently, the monitoring of internet usage and potential restriction on that usage have created a demand for customers to maintain their freedom.”

For more information, visit Hammer’s website at www.HammerCorp.info

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, May 29th, 2018 Uncategorized Comments Off on $HMMR Plans to Launch IaaS, Cloud Hosting Platform

$ETST Continues to Develop High Grade Hemp-based Products to Meet CBD Growth

  • CBD segment projected to grow to $2.1 billion by 2020
  • Global hemp-based foods market forecast to grow at a CAGR of 24 percent from 2018 to 2022
  • ETST uses cutting-edge technology to produce the highest-grade full spectrum hemp oil for product formulation

The CBD segment is one of the main drivers of the huge growth in the cannabis industry, with the Hemp Business Journal projecting this segment to grow to $2.1 billion by 2020 (http://cnw.fm/JPN3q). In addition, market research analysts Technavio forecast that the global hemp-based foods market will grow at a CAGR of over 24 percent through 2021 (http://cnw.fm/R2rcU). Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company with a primary focus on delivering high grade hemp-derived, cannabidiol (CBD)-based products to this market. It has a further focus on the development of diagnostic tools, testing processes and medical devices.

The company uses the latest supercritical CO2 cold liquid extraction method to produce the highest quality and purity full spectrum hemp oil, which is neither synthetic nor an isolate. ETST’s range of high grade cannabinoids extracted during this process contain a variety of valuable phyto-nutrients, essential oils and other naturally occurring therapeutic compounds found in the hemp plant. These are used to develop and commercialize products for the pharmaceutical and nutraceutical markets.

The company is the top brand for nutritional and dietary supplements in the industrial hemp market. ETST’s high grade CBD-rich hemp oil is classified as “food based” and is permissible in all 50 U.S. states and around 40 countries. It is used in the formulation of a wide range of CBD-infused products, including vitamins, minerals, herbs, botanicals, homeopathies, personal care products and functional foods. The company delivers its products in a variety of forms, such as capsules, soft gels, tablets, chewables, liquids, creams, sprays and powders.

ETST operates through several wholly owned subsidiaries:

  • Cannabis Therapeutics, Inc. is an emerging biotechnology company that’s poised to become a world leader in cannabinoid research and development for a broad line of cannabis and cannabinoid-based pharmaceuticals and nutraceuticals, as well as other products and solutions.
  • Earth Science Pharmaceutical, Inc. is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections (STIs) and diseases (STDs).
  • KannaBidioid, Inc. is focused on the manufacture and distribution of vapes/e-liquids and gummy edibles in the recreational space, formulated using its unique Kanna and CBD formula.

In addition, the company established a Canadian subsidiary, Canna Inno Laboratories Inc., in 2017 to give it a foothold in the Canadian cannabis market. Based in Montreal, Quebec, Canna Inno received a grant from the Government of Quebec in March 2018 to fund its innovation drive in the pharmaceutical industry. This grant will be used for the pre-launch of three of ETST’s CBD-based patented nutraceutical products to fight breast cancer and neurodegenerative disorders. The company plans to apply for more grants under the Canadian government’s Scientific Research and Experimental Development Tax Credit program.

ETST has listed several of its products for sale on its website, including raw and flavored High Grade Hemp CBD Oil tinctures, CBD veggie capsules and e-liquids in six flavors. Customers can purchase single and bulk tinctures, bulk wholesale oil, powder, vape oil and other formulations for health and wellness.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Tuesday, May 29th, 2018 Uncategorized Comments Off on $ETST Continues to Develop High Grade Hemp-based Products to Meet CBD Growth

$CIIX Cannabis and CBD Markets are Set to Increase in Value

NEW YORK, May 29, 2018

According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024. The projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms and conditions that may be treated with cannabis products include cancer, HIV, AIDS, Alzheimer’s disease, and multiple sclerosis. Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is expected to continue to dominate the cannabis industry to 2024. Chineseinvestors.com, Inc. (OTC: CIIX), Kush Bottles, Inc. (OTC: KSHB), General Cannabis Corporation (OTC: CANN), Isodiol International Inc. (OTC: ISOLF), PotNetwork Holdings, Inc. (OTC: POTN)

A major portion of the legal cannabis industry Cannabidiol products. Cannabidiol, or CBD, is one of at least 113 active cannabinoids identified in cannabis. The CBD market is growing rapidly in recent years due to CBD’s medical benefits. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: “Hemp Business Journal estimates the total retail value of all hemp products sold in the U.S. to be at least $688 million for 2016. We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.”

Chineseinvestors.com, Inc. (OTCQB: CIIX) last week announced that, “its wholly owned subsidiary, ChineseHempOil.com, Inc. (“ChineseHempOil”) has expanded its domestic sales force appointing Nina Wang Vice President of Sales for its United States Consumer Retail/E-Commerce Division on March 19, 2018, setting the stage to complete the temporarily postponed spin off of all of the Company’s hemp related assets in the near future.

Mrs. Wang has over 15 year’s sales experience in the financial services industry with over 10 years as a Merchant Services Sales Manager at USA First Credit Card, Inc. Prior to that, Mrs. Wang worked as a Sales Manager for Alliance Bank Card Services. Since joining ChineseHempOil.com, Inc. in March 2018, Mrs. Wang has hired a team of sales representatives focused on wholesale and consignment sales in the Los Angeles area.

Through her efforts, ChineseHempOil.com, Inc. has developed strategic relationships with over 70 retail establishments in the Los Angeles area to consign the ChineseHempOil OptHemp products with plans to expand to Northern California in the near future. Mrs. Wang will also play an integral role in procuring new manufacturing relationships to, continuing to brand the Opt Hemp product line and developing new cutting edge hemp products.

“With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang’s leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company’s hemp related assets. We were pleased with the 57% increase in monthly sales generated by the recent Mother’s Day Promotion and are looking forward to an even better response for the Father’s Day promotion” said Warren Wang CEO.

The Company recently announced in an 8k filing that spin-off of all of the Company’s hemp related assets, originally scheduled for May 31, 2018, has been temporarily postponed as it continues to develop its domestic sales channels.”

Kush Bottles, Inc. (OTCQB: KSHB) is a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry. Earlier this month, the company announced it has partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP). Through its partnership with MainStem, Kush Bottles will be able to tap into the dedicated MainStem customer base to distribute its ancillary cannabis products through a centralized sales platform that users can access directly from the ‘BiotrackTHC’ software, a leading seed-to-sale compliance software, they use to run their businesses.

General Cannabis Corporation (OTCQB: CANN) is the comprehensive resource for the highest quality service providers available to the regulated Cannabis Industry. On May 14, 2018, the company announced financial results for the quarter ended March 31, 2018. Robert Frichtel, Chief Executive Officer of General Cannabis, said: “General Cannabis announced first quarter financial results today. For the first quarter of 2018, we reported revenues of $942,482, a 31% increase over 2017 first quarter revenues of $719,105. Our existing operations in Colorado continue to prosper with Security, Marketing and Operations segments each showing strong year-over-year revenue growth. The team and infrastructure we have built allows us to scale with the continued expansion within cannabis industry.”

Isodiol International Inc. (OTC: ISOLF) is a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient. Recently, the company announced that it has signed a Letter of Intent (“LOI”) with Sundial Growers Inc., a privately held Alberta-based Health Canada ACMPR-approved licensed producer of medical cannabis, to import CBD isolate into Canada, subject to applicable regulatory approvals. Sundial currently operates a 31,000 square foot production facility in Rocky View, Alberta, and has two separate production facilities in various stages of completion and licensing. By 2020, it expects to be one of the leading cannabis companies in the country with a projected production of over 100 million grams of dry cannabis and the ability to process over 32 million grams of cannabis extracts.

PotNetwork Holdings, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. On May 17, 2018, the company announced that it’s wholly owned subsidiary, Diamond CBD, Inc. was showcased at Booth 65 at the Atlantic City Convention Center, where 25,000 samples of its most popular CBD infused assorted gummy bears, were enjoyed by an international crowd of counter-culture exhibitors, consumers, and vendors. Diamond CBD has a highly successful history of sales from these key trade shows. At this show the Company featured numerous products, drawing attention directly from prospective vendors on a global scale. Featured at the show were Diamond CBD’s Vape Additives, Liquid Gold Vape Juice, Chill CBD Gummies, Diamond CBD Tinctures and Biotech Creams, the Company’s most successful products.

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For chineseinvestors.com Inc. financial news dissemination and PR services, FinancialBuzz.com expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.

Media Contact:
info@financialbuzz.com
+1-877-601-1879

Url: http://www.FinancialBuzz.com

Tuesday, May 29th, 2018 Uncategorized Comments Off on $CIIX Cannabis and CBD Markets are Set to Increase in Value

$SNNVF to Announce 2018 First Quarter Results on May 30, 2018

VANCOUVER, B.C., May 25, 2018 — via NetworkWire – Sunniva Inc. (“Sunniva” or the “Company“) (CSE:SNN) (OTCQX:SNNVF)  plans to release its results for the first quarter 2018, after market close on Wednesday, May 30, 2018.

The Company’s executive management will discuss the results during a conference call on Thursday, May 31, 2018 at 11:00 am Eastern Time/8:00 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674-8052 and entering access code 2365. The replay will be available for two weeks after the call.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current Good Manufacturing Practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, May 25th, 2018 Uncategorized Comments Off on $SNNVF to Announce 2018 First Quarter Results on May 30, 2018

$PBIO Reports Increase in Revenue, Debt Conversion in Q1 2018

  • High-pressure lab equipment maker reports ninth consecutive quarter of revenue growth (Y/Y)
  • About 92 percent of debenture debt converted to preferred stock, with aim of uplisting to national stock exchange
  • Patented technologies continue to drive optimism for company’s products to enhance and improve scientific research

Pressure BioSciences, Inc. (OTCQB: PBIO), the maker of a patented and powerful line of pressure-based scientific laboratory tools, celebrated corporate gains on May 15 with the announcement of first quarter revenue growth and debenture conversion.

The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and services revenue on a year-over-year basis and the second time during the past year in which the company reported total quarterly revenue of more than $600,000. Sales of the company’s instruments established a new quarterly record, and sales of the instruments’ consumable elements increased by 18 percent following on a 21 percent revenue increase for the final quarter of 2017.

In addition to the revenue achievements, the company reported that, operationally, it was advancing in its relationships with clients as a new cadre of sales directors began working in their assigned geographical areas.

“Perhaps most exciting was the news released just today – that a majority of our 2015/2016 Convertible Debenture Holders have agreed to convert approximately $6.39M of Debentures into Series AA Preferred Stock,” CEO and President Richard T. Schumacher stated in a news release. “This represents about 92% of all 2015/2016 Debenture debt on our balance sheet as of March 31, 2018.”

Schumacher reported that discussions are ongoing with other debt holders about converting their notes into equity, which would give the company a “materially stronger” balance sheet at the end of the second quarter.

“We believe that such a change would have a significant, positive effect on the growth of PBI going forward, and would materially enhance our stated objective of up-listing to a national exchange (NASDAQ, NYSE/Amex) later in 2018,” Schumacher stated.

Pressure BioSciences is focused on the development and sale of instruments and consumables that use high pressures to break open cells in a more efficient, beneficial and reproducible way than today’s standard methods, such as mechanically “beating up” cells amid research aimed at developing medicinal and therapeutic products. The high-pressure products can also be used in counter-terrorism and criminal forensics applications.

The company’s products employ the properties of both constant (static) and alternating (cycling) hydrostatic pressure. The company’s patented pressure cycling technology (PCT) uses alternating cycles between ambient and ultra-high pressures to control biomolecular interactions in a reproducible way that allows for standards compliance reporting to government agencies.

“Because it is so powerful, unique, and enabling, Pressure Cycling Technology (PCT) could play a crucial role for the new generation of discoveries yet to be made. By carefully controlling the breakage of a cell in order to safely and reproducibly release the proteins, lipids, DNA and RNA contained inside the cell, the molecules released have been reported by numerous authors to be of greater quality, which importantly could result in newer, faster, and better discoveries,” Schumacher said in a January interview (http://nnw.fm/O7sOO).

One of Pressure BioSciences’ newest clients is a company using a patented technology platform acquired as part of Pressure BioSciences’ recent purchase of Colorado-based therapeutic drug developer BaroFold, Inc., a company Schumacher described as available at a bargain price after it “ran into some (operational) problems” that he believes Pressure BioSciences can overcome at relatively low cost. The acquisition gave Pressure BioSciences eight new pressure-related patents and extended the potential for the company’s existing patents.

This newly acquired technology platform, called PreEMT, also holds the promise that a protein drug maker might someday decide to use the company’s PreEMT technology platform in the routine manufacture of its drug to make a higher quality therapeutic, which in turn could result in the drug maker paying a hefty royalty license fee to PBI – perhaps in the millions of dollars per year. “The BaroFold technology platform offers a cutting-edge method to increase the quality and reduce the cost of manufacturing protein drugs. We’ve opened up a whole new and exciting business unit for PBI and our shareholders, one that offers the potential to generate millions of dollars in revenue, per year”, Schumacher said earlier this year.

The company also announced a co-marketing and distribution agreement with ISS, Inc., for high-pressure optical cell systems used in some lab processes. The two-year agreement will include replacing the manual pressure generator used in ISS’s product with Pressure BioSciences’ computer-controlled instruments.

For more information, visit the company’s website at www.PressureBioSciences.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, May 25th, 2018 Uncategorized Comments Off on $PBIO Reports Increase in Revenue, Debt Conversion in Q1 2018

$PVOTF Targeting Growing CBD Pet Market with New Product Line

  • Company’s new products are designed to address issues such as inflammation, joint pain, post-surgery pain and skin disorders in pets
  • CBD pet market is heating up, with a growing number of cannabis companies already manufacturing products for this niche
  • Pet owners spend more than $30 billion a year on supplements and other veterinary treatments, making CBD pet products a lucrative opportunity

The multiple uses of cannabidiol (CBD) for domesticated animals, especially for dogs and cats, are gaining considerable attention from both consumers and the cannabis industry as a whole, with a growing number of cannabis companies tapping into this lucrative market sector. Canadian-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) already has several CBD-based pet products in development, targeting indications such as inflammation, post-surgical pain and joint pain, as well as skin disorders.

Pivot recently announced that it was accelerating development of its CBD pet product line, which will be marketed under the name ‘Pivot Naturals For Pets’ (http://cnw.fm/qFl8D). This product line will include capsules and sachets to deliver bio-available CBD, using Pivot’s proprietary and patented Ready-To-Infuse-Cannabis powder. In addition, the company is using its Thrudermic Transdermal Nanotechnology to develop and commercialize a series of CBD pet creams for topical application.

“With Pivot’s line of pet products, the pain-relieving effects of CBD can be delivered orally, topically or as an additive sprinkled on pet food. Pivot’s technologies are versatile and allow us to develop and commercialize products for both the human and veterinary markets,” Dr. Joseph Borovsky, Pivot’s executive vice president, product development, stated in a news release. He added that the company’s patented technologies will allow it to continue its innovation process to bring dozens of value-added derivatives to market in Canada, the United States and the European Union.

The Canadian cannabis market is yet to reach its full potential, with an exponential increase expected this year once the country fully legalizes cannabis. Legalization, in combination with a growing demand for CBD products for pets in both Canada and the U.S., is expected to make this investment avenue a very lucrative opportunity. According to the American Pet Products Association, pet owners in the U.S. spent more than $30 billion on supplements and other veterinary treatments in 2016. The U.S. pet medicine market alone is estimated at roughly $10.2 billion.

With several studies indicating that CBD interacts in a similar way in canines and felines, making it a viable option to address a wide range of issues such as anxiety, allergies, lack of appetite, arthritis or skin problems (http://cnw.fm/NlqD6), Pivot can successfully leverage its experience and innovative manufacturing technologies to take a leading position in the CBD pet market.

The company is already well positioned to develop industry-leading, high-quality cannabinoid-based products for pharmaceutical and nutraceutical use, through proprietary drug delivery platforms via its own medical cannabis product division, Pivot Green Stream Health Solutions (“PGS”). Responsible for the research, development and commercialization of the company’s products, PGS has acquired global rights for several patented technologies, including BiPhasix™ transdermal drug delivery, Solmic oral solubilization, Thrudermic Transdermal Nanotechnology and Ready-to-Infuse-Cannabis powder-to-oil technology. These technologies are at the foundation of the company’s pipeline of pharmaceutical products, which target different ailments and conditions ranging from cancer supportive care to glaucoma, women’s sexual desire disorder, dermatological conditions, opioid withdrawal, pain and inflammation, and many others.

For more information, visit the company’s website at www.PivotPharma.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Friday, May 25th, 2018 Uncategorized Comments Off on $PVOTF Targeting Growing CBD Pet Market with New Product Line

$HMMR NetworkNewsAudio Announces Audio Press Release

New York, New York–(May 25, 2018) – NetworkNewsAudio announces the Audio Press Release (APR) titled “Everything Wireless Approach Key to Capturing Nascent 5G Market,” featuring Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR).

To hear the NetworkNewsAudio version, visit http://nnw.fm/n9dnE

To read the original editorial, visit http://nnw.fm/6yFit

Hammer Fiber Optics’ (HMMR) patented AIR System was designed around and is based on ultra-high-frequency MMDS (multichannel multipoint distribution system), utilizing frequency division duplexing for upstream and downstream (200 MHz spacing). This enables a single transmission to be shared by multiple independent signals. With such efficient use of the spectrum, Hammer’s AIR System can handle two separate signals at once across a wide range of frequencies (from 3 GHz to 39 GHz), meaning spectrum in different frequencies and channels can be processed by one transceiver. This pre-5G platform is DOCSIS 3.0 compliant and is scalable to DOCSIS 3.1, allowing for speeds of 1 Gb/s and up.

Using a simple, roof-mounted, bidirectional transceiver dish that is then connected to standard in-home hardware such as a cable modem or gateway via coaxial cable, Hammer Fiber Optics’ solution is an ingenious marriage of cutting-edge wireless transmission technology and the kind of equipment most consumers already have in their homes. The company has already deployed this technology on Absecon Island, including Atlantic City, N.J., with happy customers seeing speeds around 300-plus Mbps downstream (100 Mbps upstream). The recent announcement that the company concluded initial development of its advanced LTE fixed wireless system means Hammer is now poised to become a leader in 5G as the standard emerges (http://nnw.fm/jE6Et).

About Hammer Fiber

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) is a telecommunications company investing in the future of wireless technology whose holdings include Hammer Fiber Optic Investments, Ltd. D/B/A Hammer Communications, that offers internet, voice, video and data services in New Jersey, through both direct fiber as well as its wireless fiber platform, Hammer Wireless® AIR technology. The Hammer Wireless Air technology can support a variety of applications including mobile-to-mobile, wireless DOCSIS, IoT and Smart City support as well as pre-5G network applications. For more information, visit the company’s website at www.HammerComm.com

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) is another NetworkNewsWire (NNW) Solution that can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, May 25th, 2018 Uncategorized Comments Off on $HMMR NetworkNewsAudio Announces Audio Press Release

$ETST Growth Through Product Development, JVs and Acquisitions

  • 12 more U.S. states likely to approve medicinal or recreational use of cannabis in 2018
  • Hemp-derived CBD market on course for CAGR of 55 percent over next five years
  • Ventures in both MMJ and recreational marijuana hedge bets

The tide of cannabis legalization sweeping over North America continues to rise despite intractable federal prohibition in the United States. In the U.S., 29 states and the District of Columbia allow cannabis for medical use. In nine of those jurisdictions, adult recreational use is also permitted. Another 12 are considering easing restrictions on cannabis use by the end of the year. In Canada, the recreational market is set for opening by fall. As a result, the cannabis market outlook is bright. A recent report valued the global legal cannabis market at $14.3 billion in 2016 and projected a compound annual growth rate (CAGR) of 21.1 percent until 2024, to reach $63.5 billion (http://cnw.fm/W6fPx). In the fastest growing segment of this market is where you will find innovative biotechnology company Earth Science Tech, Inc. (OTC: ETST). The hemp-derived CBD market, in which it operates, is ballooning at a CAGR of 55 percent. At that rate, it will cross the billion-dollar mark in five years. With its ventures in leading edge, cannabinoid-based pharmaceutical and nutraceutical products, ETST is poised to share in that market growth.

Fuel is being added to the cannabis fire. In November 2018, initiatives allowing recreational use are likely to be on the ballot in six states, including Connecticut, Delaware, Michigan, New Jersey, Ohio and Rhode Island. Vermont has already been there and done that. In January 2018, the state legislature passed a bill allowing recreational use, the first and only state to do so prompted by legislative initiative, rather than by being put to voters at ballot. In five more states – Kentucky, Missouri, Oklahoma, South Dakota and Utah – legalization questions on medical marijuana may face voters in November 2018, according to Newsweek  (http://cnw.fm/iK1HV). If cannabis continues on its roll, 41 states and DC will have legalized cannabis for medicinal purposes, while 15 and DC will permit adult recreational use, by the end of 2018.

To enter this brave new world of cannabis liberalization, ETST is developing a portfolio of new products while aggressively pursuing growth through joint ventures and acquisitions. In this vein, newly created division Cannabis Therapeutic Inc. will develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products based on an existing CBD patent. The company continues its activities in the hemp-derived cannabinoid (CBD), nutraceutical, pharmaceutical and medical device markets. In addition, it is pursuing a vigorous program of R&D and continued development of its marketing and distribution channels.

The company’s purchase of Canna Inno Laboratories Inc. is already paying off. The acquisition, partly designed to gain access to Canadian government funding, has scored on that front. In March 2018, ETST announced that Canna Inno Laboratories had received a supporting grant for innovation in the pharmaceutical industry from the Ministère de l’économie, des sciences et de l’innovation of the Government of Québec.

This first grant is earmarked for the pre-launch processes on the company’s three CBD-based nutraceutical provisional patent products. The pre-launch process includes a series of pre-clinical in vitro trials to fight breast cancer and neurodegenerative disorders. Thereafter, patent applications will be submitted, with the products expected to be commercialized as nutraceuticals during the waiting period. The company also plans to apply for more funding under Canada’s Scientific Research and Experimental Development Tax Credit program, among others. Earth Science expects that, through this new subsidiary, about half of all R&D expenditures will be covered by grants.

ETST is also venturing into the recreational market. A joint venture with Karmavore SuperFood is set to manufacture a new chocolate product, and one with Varsity Group, LLC, a kanna ingredient based e-liquid company, will give Earth Science a presence in the recreational vape/smoke market.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Friday, May 25th, 2018 Uncategorized Comments Off on $ETST Growth Through Product Development, JVs and Acquisitions

$CIIX Featured on MoneyTV with Donald Baillargeon, 5/25

LOS ANGELES, CA / May 25, 2018 / Spirits industry, CBD, cryptocurrrency, cannabis, Swamp-Gate; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.

Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.

The television program can also be viewed online immediately at www.moneytv.net.

Featured companies on this week’s program include:

Imaging3, Inc. (OTCQB: IGNG) CEO John Hollister talked about progress made in their regulatory efforts.

Blu Tango, Inc. President Michael Manahan discussed how the spirits industry is changing and introduced some of their SKU product line.

ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang reported on company progress from New York City.

Singlepoint, Inc. (OTCQB: SING) CEO Greg Lambrecht discussed the favorable meetings they’ve had with investment bankers in New York this week.

Premier Biomedical, Inc. (OTC PINK: BIEI) CEO William Hartman discussed the trade show reaction to the company’s line of CBD pain relief products.

A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net.

MoneyTV Executive Producer and Anchor Donald Baillargeon is also the host of MoneyRap Radio, http://www.moneyrap.com and the television program Crowdfund Television, http://www.crowdfundtelevision.com.

MoneyTV with Donald Baillargeon television program, Copyright MMXVIII, all rights reserved. MoneyTV does not provide an analysis of companies’ financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,995.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producer, publisher or parent company of MoneyTV.

Contact:

Donald Baillargeon
info@moneytv.net
949 388 5267

Friday, May 25th, 2018 Uncategorized Comments Off on $CIIX Featured on MoneyTV with Donald Baillargeon, 5/25

$VSQTF Partners With Keynote to Bring World Blockchain Forum to NYC

VANCOUVER, British Columbia, May 24, 2018  — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CNX:VST) (OTC:VSQTF) (FWB:6F6) is partnering with Keynote to bring the World Blockchain Forum to New York City for the first WBF: Security Tokens & ICOs conference on June 12-13, 2018.

The two-day conference will bring together more than 1,000 major stakeholders in the blockchain and cryptocurrency space. Building on the previous World Blockchain Forum theme of “ICOs and Investments”, next month’s event will introduce New York to fintech industry leaders, inspiring speakers, experts and innovators from around the globe, opening up dialogue designed to explore security tokens in blockchain.

“Although bitcoin and blockchain technology are rapidly becoming more understood, security tokens remain a black box to most people,” noted Moe Levin, Founder & CEO of Keynote. “That will inevitably change and change fast because in our view the only real way to unlock the next trillion dollars of value in the ecosystem is by digitizing the traditional financial world through security tokens. Showcasing the best and brightest in the industry has been the aim of Keynote since 2012, and we’re excited to be bringing the 7th edition of the World Blockchain Forum to New York City.”

Peter Smyrniotis, a member of the Board of Directors of Victory Square and CEO of Blockchain Assembly Inc. (“Blockchain Assembly”), will be speaking on the main stage on June 12, 2018, at 10:50 am (EDT). The combined Victory Square and Blockchain Assembly teams will also be hosting a $100,000 USD Investment Prize pool for the top three blockchain companies during the WBF’s Pitch Your ICO session.

Notable ICOs that have launched with Keynote include Ethereum (which is currently at a $27 billion USD market cap), Litecoin ($2.5 billion market cap), Dash ($2 billion), Factum ($70 million) and Blockchain Capital ($30M).

Keynote Events has hosted 14 global blockchain-focused conferences in the past five years, including London, Brussels, Dubai, Los Angeles, Miami, Amsterdam and Chicago. WBF speakers are typically recognized as innovators, thought leaders and decision makers in the blockchain and currency industries. Past speakers have included: Roger Ver, CEO of Bitcoin.com; Halsey Minor, Founder of CNET and Founder of Uphold; Craig Sellars, Co-Founder of Tether; Brock Piere, Co-Founder of Blockchain Capital; Sasha Ivanov, Founder & CEO of Waves Platform; William Quigley, Founder of WAX; Diego Gutierrez Zaldivar, CEO & Co-Founder of RSK Labs; Adam Perlow, Founder of Zen Protocol; and both Dr. Levin and Mr. Smyrniotis.

“Having already partnered with the WBF on two of 2018s biggest bitcoin and blockchain events in Miami and Dubai, Victory Square is excited to bring the World Blockchain Forum to the Big Apple,” said Shafin Diamond Tejani, CEO of Victory Square. “These conferences are strategically essential for us and New York will allow us to connect with the some of the most respected blockchain thought-leaders, institutional investors, regulators, leading companies and projects in the world, while at the same time showing off our own exceptional entrepreneurs and portfolio companies.”

A key for Victory Square are the Pitch Your ICO sessions where it will gain valuable insight from founders of the most promising upcoming blockchain companies. With over 30 leading blockchain companies selected to attend from all over the world to present to some of the leading cryptocurrency investors, Victory Square will judge and select three winners who will share in the special $100,000 USD prize pool.

“Victory Square continues to be a great supporter of not only the World Blockchain Forum but of the entire blockchain and crypto space,” added Keynote CEO Dr. Levin. “We are pleased once again to have Victory Square as a lead sponsor as they represent some of the most sophisticated minds in the industry today. With an already impressive and growing portfolio of blockchain-enabled assets under the Victory Square umbrella we look forward to seeing them showcase their talented teams in New York City.”

For further information about the Company, please contact:

Investor Relations Contact – Prit Singh
Email: prit@victorysquare.com
Telephone: 905-510-7636

Media Contact – Howard Blank, Director
Email: howard@victorysquare.com
Telephone: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance by any portfolio company of the Company, the impact of any portfolio company’s performance on the Company, the strategic direction of the Company, and its goal of broadening its portfolio of interests in innovative companies. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical fact contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Thursday, May 24th, 2018 Uncategorized Comments Off on $VSQTF Partners With Keynote to Bring World Blockchain Forum to NYC

$NETE SeeThruEquity Issues Update

NEW YORK, NY / May 24, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update on Net Element, Inc. (NASDAQ: NETE).

The note is available here: NETE May 2018 Update Note.

Net Element, Inc. (Nasdaq CM: NETE, “Net Element”) is a global financial technology and value-added solutions company that supports payment technology solutions, online payments and value-added transactional services in emerging countries and in the United States. The company is headquartered in Miami Beach, Florida.

Highlights from the update include:

 

Net Element reported first quarter FY 2018 results on May 14, 2018. Results were highlighted by strong growth in transaction volume, particularly in North America, and narrowing losses. Highlights of the announcement are as follows:

 

  • 1Q18 revenues grew by 18% YoY. Net Element reported 1Q18 revenues of $16.0mn, which which represented an increase of approximately 18% versus $14mn in the year-ago period.

 

  • Revenue growth was again driven by strong execution in the company’s North America Transactions Solutions business segment, which grew by 27% YoY to reach $14mn. International Transactions, which represents a much smaller portion of revenues, declined by 22% YoY to $2mn.

 

  • Transaction dollar volume rises by 51% in 1Q18. Net Element reported that transaction dollars processed on its platform increased by an impressive 51% to reach $839mn in 1Q18 versus $557mn in 1Q17.

 

  • Total number of transactions also increased to 30mn, versus 27mn during 1Q17. This represented an increase of 11% YoY.

 

  • NETE reported a Net Loss of ($1.6mn) in 1Q18, versus a loss of ($2.5mn) in 1Q17. The company benefitted from lower G&A, professional fees and rent during the period.

 

  • NETE reported GAAP EPS of ($0.42) in 1Q18, versus ($1.51) in 1Q17. Average shares outstanding during 1Q18 was $3.9mn.

 

 

  • Net Element launched its new multi-channel payments platform during 1Q18, Netevia. According to the company, Netevia is a new platform that connects and simplifies payments across a number of channels through a single integration point – including POS, e-commerce, and mobile devices. The company is also integrating new technology into Netevia, which will make it a decentralized blockchain technology solution.

 

  • During the quarter NETE named two new members to its Board of Directors, CNBC host Jon Najarian and Bank of America veteran and fintech executive Jonathan Fichman. Both new members will serve on the company’s Audit, Nominating and Corporate Governance, and Compensation Committees.

 

No change to target following results

The price target remains unchanged for Net Element. NETE has demonstrated double-digit growth and an improved balance sheet, with additional growth potential from new blockchain initiatives. We would look to re-evaluate the target as the company updates investors on its progress and clarifies expectations for blockchain in 2018-2019.

Please review important disclosures in the report and on our website at www.seethruequity.com.

About Net Element, Inc.

Net Element, Inc. (Nasdaq: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S. it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant and retail point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™ and South Florida Business Journal’s 2016 fastest growing technology companies. Further information is available at www.netelement.com.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative approach to deliver equity research of microcap and smallcap companies. SeeThruEquity has also been the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion since 2012.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information visit www.seethruequity.com.

Contact:
SeeThruEquity
info@seethruequity.com

Thursday, May 24th, 2018 Uncategorized Comments Off on $NETE SeeThruEquity Issues Update

$HMMR NetworkNewsWire Publication on Data-Hungry Market

NEW YORK, May 24, 2018 — via NetworkWire — NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Hammer Fiber Optics Holdings Corp. (OTCQB:HMMR), a client of NNW and telecommunications company investing in the future of wireless technology.

To view the full publication, titled “Everything Wireless Approach Key to Capturing Nascent 5G Market,” visit: http://nnw.fm/6yFit

The subsequent announcement that Hammer and 1stPoint have launched an MNSP (mobile network service provider) program aimed at wireless internet service providers and cable operators in second- and third-tier markets means that the company should be able to quickly expand its subscriber base by offering high-speed wireless triple play service to residential communities and small businesses. Hammer’s founder, Mark Stogdill, was keen to point out how the company now stands ready to support not only residential access networks but also empower customers such as carriers and municipalities to deploy a variety of applications through the company’s network. The MNSP program enables an “everything wireless” approach that could potentially shatter the existing triple play-saturated market paradigm.

This is a watershed moment for Hammer as the company may be in a great position to springboard off its successful deployment of the AIR System into a data-hungry nationwide, as well as global, market. Hammer’s AIR System is now looking to many industry analysts like it may be the ideal solution for everything from bridging the digital divide in underserved rural communities to addressing increasingly abundant data roaming opportunities and M2M concerns. This innovative, patented technology represents what could be a major advantage for the company, as no one in the industry today offers what Hammer is already doing.

About Hammer Fiber

Hammer Fiber Optic Holdings Corp. (OTCQB:HMMR) is a telecommunications company investing in the future of wireless technology whose holdings include Hammer Fiber Optic Investments, Ltd. D/B/A Hammer Communications, that offers internet, voice, video and data services in New Jersey, through both direct fiber as well as its wireless fiber platform, Hammer Wireless® AIR technology. The Hammer Wireless Air technology can support a variety of applications including mobile-to-mobile, wireless DOCSIS, IoT and Smart City support as well as pre-5G network applications. For more information, visit the company’s website at www.HammerComm.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, May 24th, 2018 Uncategorized Comments Off on $HMMR NetworkNewsWire Publication on Data-Hungry Market